Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
PaperCitations, authors & open-access status
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 228 citations, 2022 year and green oa status.
228
Citations
2022
Year
green
OA Status